The purpose of this study is to evaluate bone mineral density (BMD) and bone turnover markers in men with ankylosing spondylitis (AS) and to determine their relationship with clinical features and disease activity. Serum carboxi terminal cross-linked telopeptide of type I collagen (CTX), osteocalcin
Ankylosing spondylitis and bone mineral density—what is the ideal tool for measurement?
✍ Scribed by Uwe Lange; A. Kluge; J. Strunk; J. Teichmann; G. Bachmann
- Publisher
- Springer
- Year
- 2004
- Tongue
- English
- Weight
- 228 KB
- Volume
- 26
- Category
- Article
- ISSN
- 0172-8172
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Summary Osteoporosis is a well recognized complication of ankylosing spondylitis (AS). This study indicates that increased bone turnover, inflammation, and low vitamin D levels are important in the pathophysiology of AS-related osteoporosis, and that bone turnover markers (BTM) are valuable mark
## Abstract ## Objective To select the most appropriate radiologic scoring method for the evaluation of radiographic progression in ankylosing spondylitis (AS) in clinical trials. ## Methods The validity of the currently available methods, the Bath Ankylosing Spondylitis Radiology Index (BASRI),
The sensitivity of bone mineral density (BMD) as a predictor of fracture risk is limited by the fact that this index does not take into account the geometrical and material characteristics of bone. In contrast, both BMD and bone architecture influence the quality factor (QF), the fraction of the inv
## Abstract The role of type 2 deiodinase (D2) in the human skeleton remains unclear. The D2 polymorphism Thr92Ala has been associated with lower enzymatic activity, which could result in lower local triiodothyronine (T~3~) availability in bone. We therefore hypothesized that the D2 Thr92Ala polymo